Low Expression of Circulating MicroRNA-34c is Associated with Poor Prognosis in Triple-Negative Breast Cancer
Authors:
Open Access
- 1 January 2017
- journal article
- research article
- Published by Yonsei University College of Medicine in Yonsei Medical Journal
- Vol. 58 (4) , 697-702
Abstract
Zeng Z, et al. Yonsei Med J. 2017 Jul;58(4):697-702. https://doi.org/10.3349/ymj.2017.58.4.697Keywords
This publication has 21 references indexed in Scilit:
- MicroRNA-34c Suppresses Breast Cancer Migration and Invasion by Targeting GIT1Journal of Cancer, 2016
- Expression of miR-34c induces G2/M cell cycle arrest in breast cancer cellsBMC Cancer, 2014
- The p53/miR-34 axis in development and diseaseJournal of Molecular Cell Biology, 2014
- Mir-34: A New Weapon Against Cancer?Molecular Therapy Nucleic Acids, 2014
- Downregulation of miR-34a in breast tumors is not associated with either p53 mutations or promoter hypermethylation while it correlates with metastasisMedical Oncology, 2013
- MicroRNA 34c Gene Down-regulation via DNA Methylation Promotes Self-renewal and Epithelial-Mesenchymal Transition in Breast Tumor-initiating CellsJournal of Biological Chemistry, 2012
- MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancerCell Cycle, 2011
- Triple-Negative Breast CancerNew England Journal of Medicine, 2010
- Frequent Downregulation of miR-34 Family in Human Ovarian CancersClinical Cancer Research, 2010
- Molecular portraits of human breast tumoursNature, 2000